Evidence map›Paper›PMID 21969075›Full record

ArticleJournal of autism and developmental disorders2012

The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients.

Dario Siniscalco, Anna Sapone, Catia Giordano, Alessandra Cirillo, Vito de Novellis, Laura de Magistris, Francesco Rossi, Alessio Fasano, Sabatino Maione, Nicola Antonucci

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD).The Cochrane database of systematic reviews · 2016
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Stem cell therapy in autism: recent insights.Stem cells and cloning : advances and applications · 2018
    Review
  14. Article
  15. High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders.International journal of developmental disabilities · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dario SiniscalcoDepartment of Experimental Medicine, Division of Pharmacology, Second University of Naples, via S Maria di Costantinopoli 16, 80138 Naples, Italy. dariosin@uab.edu
Anna Sapone
Catia Giordano
Alessandra Cirillo
Vito de Novellis
Laura de Magistris
Francesco Rossi
Alessio Fasano
Sabatino Maione
Nicola Antonucci
University of Campania "Luigi Vanvitelli" · ITUniversity of Naples Federico II · ITUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism and autism spectrum disorders (ASDs) are heterogeneous complex neuro-developmental disorders characterized by dysfunctions in social interaction and communication skills. Their pathogenesis has been linked to interactions between genes and environmental factors. Consistent with the evidence of certain similarities between immune cells and neurons, autistic children also show an altered immune response of peripheral blood mononuclear cells (PBMCs). In this study, we investigated the activation of caspases, cysteinyl aspartate-specific proteases involved in apoptosis and several other cell functions in PBMCs from 15 ASD children compared to age-matched normal healthy developing controls. The mRNA levels for caspase-1, -2, -4, -5 were significantly increased in ASD children as compared to healthy subjects. Protein levels of Caspase-3, -7, -12 were also increased in ASD patients. Our data are suggestive of a possible role of the caspase pathway in ASD clinical outcome and of the use of caspase as potential diagnostic and/or therapeutic tools in ASD management.

Indexed as

ApoptosisBlotting, WesternCaspasesChildChild Development Disorders, PervasiveChild, PreschoolFemaleGene Expression Regulation, EnzymologicHumansMaleMicroscopy, FluorescenceMonocytesReference ValuesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerCaspasesRNA, Messenger

Identifiers

PMID21969075
OpenAlexW2072675843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.